Health Care and Pharma | Research Reports, News, Events, Research on Demand

Research Reports Titles

  • Ovarian Cancer - Pipeline Review, H1 2016

    Ovarian Cancer - Pipeline Review, H1 2016 Summary Global Markets Direct s,  Ovarian Cancer - Pipeline Review, H1 2016 , provides an overview of the Ovarian Cancer pipeline landscape. The report provides comprehensive information on the therapeutics under development for Ovarian Cancer, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Ovarian Cancer and features dormant and discontinued projects. Global Markets Direct s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data. Scope - The report provides a snapshot of the global therapeutic landscape of Ovarian Cancer - The report reviews pipeline therapeutics for Ovarian Cancer by companies and universities/research institutes based on information derived from company and industry-specific sources - The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages - The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved Ovarian Cancer therapeutics and enlists all their major and minor projects - The report assesses Ovarian Cancer therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type - The report summarizes all the dormant and discontinued pipeline projects - The report reviews latest news related to pipeline therapeutics for Ovarian Cancer Reasons to buy - Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of therapeutics under development for Ovarian Cancer - Identify potential new clients or partners in the target demographic - Develop strategic initiatives by understanding the focus areas of leading companies - Plan mergers and acquisitions effectively by identifying key players and it s most promising pipeline therapeutics - Devise corrective measures for pipeline projects by understanding Ovarian Cancer pipeline depth and focus of Indication therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

    • Release Date: June 28, 2016
    • Price: USD 2500
    • Format: pdf

  • North America Non-Gelatin Empty Capsules Market Research Report 2015-202

    is report studies the sales and future of electric shaver in North America market, especially in USA, Canada, and Mexico. This report focuses on the top players in these countries, involving the Sales, price, revenue and market share (competition situation), from 2011 to 2015, and forecast to 2021. On the basis of segments by products of each manufactures, this report focuses covering price, sales and market share of each type in 2015 and 2016 as well as the types and each type price of key manufacturers, through interviewing key manufacturers. Split by Countries, covering sales and market share of each country in 2015, and forecast to 2020. USA Canada Mexico Types Cellulose Esters Empty Capsules (including HPMC, MC, EC) Plant Polysaccharides Empty Capsules (including Pullulan and Trehalose) Plant starch capsules Application Drug package Dietary Supplement Package Top players in North America Market, covering price of each type, sales, revenue and market share in North America market. Qualicaps ACG-Associated Capsules Suheung Capsule Co., Ltd. Farmacapsules Capscanada Hunan Er-Kang Pharmaceutical Co., Ltd. GoCaps Levecaps Empty caps company Healthcaps USA Excellent Health Products Co.,Ltd Biocaps Purecaps USA Capsuledepot With 128 pages, 175 charts and seven chapters, to display the market present situation and future, clearly and deeply.

    • Release Date: June 17, 2016
    • Price: USD 2750
    • Format: PDF

Create Account

Log In Your Account